Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 346.32M | $ 95.8M | $ 0 | $ 0 | -27.66% |
3/31/2025 | $ 171.72M | $ 7.35M | $ 0 | $ 0 | -4.28% |
12/31/2024 | $ 49.42M | $ 7.52M | $ 0 | $ 0 | -15.22% |
9/30/2024 | $ 78.26M | $ 5.52M | $ 0 | $ 0 | -7.05% |
6/30/2024 | $ 92.18M | $ 35.19M | $ 0 | $ 0 | -38.17% |
3/31/2024 | $ 326.48M | $ 30.4M | $ 0 | $ 0 | -9.31% |
12/31/2023 | $ 169.98M | $ 30.23M | $ 0 | $ 0 | -17.78% |
9/30/2023 | $ 85.75M | $ 30.18M | $ 0 | $ 0 | -35.19% |
6/30/2023 | $ 112.84M | $ 507K | $ 0 | $ 0 | -0.45% |
3/31/2023 | $ 114.1M | $ 641K | $ 0 | $ 0 | -0.56% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for CYTOMX THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 4.27M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 326.81M ]
(=) Shareholder Yield [ -1.31% ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |